Search Results

Aphaia Reports Positive Results from Phase 2 Trial Evaluating Lead Drug Formulation for Prediabetes Treatment.

• Source: Manufacturing Close-Up. 2024.

Record details

Aphaia Highlights Positive Results from Phase 2 Trial Evaluating Lead Drug Formulation for Prediabetes Treatment.

• Source: Professional Services Close-Up. 2024.

Record details

Aphaia Reports Positive Results from Phase 2 Trial Evaluating Lead Drug Formulation for Prediabetes Treatment.

• Source: Entertainment Close-up. 2024.

Record details

Aphaia Reports Positive Results from Phase 2 Trial Evaluating Lead Drug Formulation for Prediabetes Treatment.

• Source: Health & Beauty Close-Up. 2024.

Record details

Aphaia Highlights Positive Results from Phase 2 Trial Evaluating Lead Drug Formulation for Prediabetes Treatment.

• Source: Wireless News. 2024.

Record details

Aphaia Updates on Positive Results from Phase 2 Trial Evaluating Lead Drug Formulation for Prediabetes Treatment.

• Source: Wireless News. 2024.

Record details

Awareness of use of GLP-1 agonists in the treatment of Diabetes Mellitus in Pakistan

• Source: Journal of Pakistan Medical Association. August 31, 2023, Vol. 73 Issue 8, 1769

Record details

Calibrate Sets New Benchmark in Obesity Treatment: Demonstrates a Remarkable 18% Sustained Weight Loss for Members at 24 Months, Outperforming GLP-1 Medication Trials.

• Source: Business Wire. 2024.

Record details

Clinical Impact of Liraglutide as a Treatment of Obesity

• Authors : Alruwaili, Heshma; Dehestani, Babak; Roux, Carel Wile

• Source: Clinical Pharmacology: Advances and Applications. March 31, 2021, Vol. 13, p53, 8 p.

Record details

Diabetes drug could be approved to treat obese patients.

• Source: Daily Telegraph (London, England). 2023, pages. 2

Record details